close

Enter

Log in using OpenID

Actinic Keratosis Treatment Market Global Trends, Market Share, Industry Size, Growth, Opportunities, and Market Forecast 2019 to 2029

embed
Global Actinic Keratosis Treatment Market Introduction: Global Actinic Keratosis Treatment Market is calculated to value over USD 8.5 Billion by 2029 end and register a CAGR of over 4% from 2019 to 2029. Actinic keratosis is caused due to overexposu
Actinic Keratosis Treatment Market Global Trends, Market Share, Industry Size,
Growth, Opportunities, and Market Forecast 2019 to 2029
Global Actinic Keratosis Treatment Market Introduction:
Global Actinic Keratosis Treatment Market is calculated to value over USD 8.5 Billion
by 2029 end and register a CAGR of over 4% from 2019 to 2029.
Actinic keratosis is caused due to overexposure to the harmful UV rays. Face and
back of the palm are the primary areas where actinic keratosis is prominently
observed. It can cause skin cancer if neglected for long. This is primarily observed in
regions with a thin layer of ozone and these are the potential market regions for
actinic keratosis treatment.
Global Actinic Keratosis Treatment Market Overview:
Based on the type of treatment provided, the market is bifurcated into topical
treatment, photodynamic therapy and procedural modality. Topical treatment is
further segmented in to 5-fluorouracil cream, diclofenac gel, Imiquimod cream and
Ingenol mebutane gel while procedural modality is sub-segmented into chemical
peels and cryotherapy.
Bassed on the end user, the market is bifurcated into hospitals, private dermatology
clinics, laser therapy centres, cancer treatment centres, spas & rejuvenation centre
and home care. Homecare segment has good potential for market growth as there
has been an increase in consumer awareness and the availability of various self-care
affordable options thus targeting the emerging economic market space. By the type
of disease, the market is segmented into clinical actinic keratosis and sub-clinical
actinic keratosis.
Global Actinic Keratosis Treatment Market Regional Insight:
North America dominates this market and will continue to do the same during the
forecast period. North America has a thin ozone layer exposing it to the harmful
ultraviolet rays and as a result of this, the majority of actinic keratosis patients are
from this region.
However, the European region is also making significant progress in this market and
will achieve a high value of CAGR during the forecast period. The middle east &
African region account for the least market share owing to low per person income
which makes the treatment inaccessible to the masses.
Request a Sample Report @ https://www.futurewiseresearch.com/requestsample.aspx?id=250&page=requestsample
Insights on Global Actinic Keratosis Treatment Market:
1. By Region
• North America
• Europe
• Asia Pacific
• Middle East & Africa
• Latin America
Actinic keratosis is prominently observed in the North American region due to the presence of a
thin ozone layer in the region and hence this region dominates the global market. Additionally,
patients highly prefer minimally invasive treatments and they are capable of spending on such
treatments which drives the market further. Furthermore, the majority of the vendors providing
minimally invasive treatments are present in the U.S which strengthens their market position
thus resulting in their domination over the market.
Asia Pacific region has huge potential for substantial market growth. Australia in particular has a
prominent occurrence of actinic keratosis and it is found in around 40%-50% of the adult
population. Creating awareness regarding actinic keratosis and implementation of efficient social
insurance are some of the factors that will help this market space to strengthen its position.
2.
•
o
o
o
o
By Treatment Type
Topical Treatment
5-Fluorouracil Cream
Diclofenac Gel
Imiquimod Cream
Ingenol Mebutane Gel
• Photodynamic Therapy (PDT)
• Procedural Modality
o Chemical Peels
o Cryotherapy
Topical medications dominated this market in 2018 due to its profound market penetration and
easy availability. Additionally, this treatment has a low risk of creating scars on a patient’s body
which drives this segment further.
Photodynamic treatment is the fastest growing segment due to a reduction in the number of
treatment sessions and a rising interest in non-obtrusive surgeries.
3. By End User
• Hospitals
• Private Dermatology Clinics
• Laser Therapy Centres
• Cancer Treatment Centres
• Spas & Rejuvenation Centres
• Home Care
Hospital segment dominates this market due to the ease of accessibility and availability of actinic
keratosis treatments to patients. The key driving factor for this segment to grow is the rise in
healthcare services.
Homecare is expected to witness rapid market growth during the forecast period. This is due to
a rise in the awareness of consumers and the plethora of self-care treatment options that are
available and are affordable to everyone.
4. By Disease Type
• Clinical Actinic Keratosis
• Sub-Clinical Keratosis
Prominent Players:
• Galderma
• DUSA Pharmaceuticals
• Athenex Inc.
• Chongqing Jingdong Junzhou Pharmaceuticals Co. Ltd
• Bausch Health Companies Inc.
• LEO Pharma A/S
• Sun Pharmaceutical Industries Ltd.
• Novartis International AG
• Hill Dermaceuticals
Athenex Inc. and Chongqing Jingdong Junzhou Pharmaceuticals Co. Ltd announced a
partnership in January 2019 for the development of an ointment KX2-391 for treating actinic
keratosis in China. This partnership will be helpful for both the parties to strengthen their market
position considering how big and important the Chinese market region is.
Purchase a Copy & Ask For Discount:
https://www.futurewiseresearch.com/requestsample.aspx?id=250&page=askfordiscount
Competitive Landscape:
● Tier 1 players- established companies in the market with a major market share
●
Tier 2 players
●
Emerging players which are growing rapidly
●
New Entrants
FutureWise Key Takeaways:
• Growth prospects
• SWOT analysis
• Key trends
• Key data-points affecting market growth
Objectives of the Study:
• To provide with an exhaustive analysis on the global actinic keratosis treatment market by
region, by treatment type, by end user, by disease type
• To cater comprehensive information on factors impacting market growth (drivers, restraints,
opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions (along with countries)— North America, Europe,
Asia Pacific, Middle East & Africa and Latin America
• To record evaluate and competitive landscape mapping- product launches, technological
advancements, mergers and expansions
• Profiling of companies to evaluate their market shares, strategies, financials and core
competencies
Table of Contents
1. Market Introduction


Market Taxonomy
Market Definition

Exclusion and Inclusion
2. Executive Summary


Market Overview
Market Analysis
3. Market Opportunity Analysis


Macro-Economic Factors
Opportunity Analysis
4. Market Dynamics



Drivers
Restraints
Trends
5. Actinic Keratosis Treatment Market by Treatment Type
Topical Treatment
o
o
o
o
5-fluorouracil Cream
Diclofenac Gel
Imiquimod Cream
Ingenol mebutate Gel
Procedural Modality
o
o
Chemical Peels
Cryotherapy
Photodynamic Therapy
Market Size (US$ Mn) Forecast By Treatment Type, 2019-2029
6. Actinic Keratosis Treatment Market by Disease Type
o
o
Clinical AK
Subclinical AK
Market Size (US$ Mn) Forecast By Disease Type, 2019-2029
7. Actinic Keratosis Treatment Market by End User
Historical Market Size (US$ Mn) Trend Analysis By End User, 2014-2018
o
o
o
o
o
o
Hospitals
Private Dermatology Clinics
Laser Therapy Centers
Cancer Treatment Centers
Spas and Rejuvenation Centers
Homecare
Market Size (US$ Mn) Forecast By End User, 2019-2029
8. North America Actinic Keratosis Treatment Market Analysis 2014–2018 and Forecast 2019–
2029
o
o
o
o
Introduction
Historical Market Size (US$ Mn) Analysis By Country, 2014-2018
Market Size (US$ Mn) Forecast By Country, 2019-2029
Historical Market Size (US$ Mn) Trend Analysis By Treatment Type, 2014-2018
9. Latin America Actinic Keratosis Treatment Market Analysis 2014–2018 and Forecast 2019–
2029
o
o
o
o
o
o
Introduction
Regional Market Trends
Historical Market Size (US$ Mn) Analysis By Country, 2014-2018
Brazil
Mexico
Rest of Latin America
10. Western Europe Actinic Keratosis Treatment Market Analysis 2014–2018 and Forecast 2019–
2029
o
o
o
o
o
o
o
o
Introduction
Historical Market Size (US$ Mn) Analysis By Country, 2014-2018
Germany
U.K
France
Italy
Spain
Rest of Western Europe
11. Eastern Europe Actinic Keratosis Treatment Market Analysis 2014–2018 and Forecast 2019–
2029
o
o
o
Introduction
Historical Market Size (US$ Mn) Analysis By Country, 2014-2018
Russia
o
o
Poland
Rest of Eastern Europe
12. Asia Pacific Excluding Japan Actinic Keratosis Treatment Market Analysis 2014–2018 and
Forecast 2019–2029
o
o
o
o
o
o
o
Introduction
Historical Market Size (US$ Mn) Analysis By Country, 2014-2018
India
Australia and New Zealand
China
ASEAN
Rest of APECJ
13. Middle East and Africa Actinic Keratosis Treatment Market Analysis 2014–2018 and Forecast
2019–2029
o
o
o
o
o
Introduction
Historical Market Size (US$ Mn) Analysis By Country, 2014-2018
GCC Countries
South Africa
Rest of Middle East and Africa
14. Competition Analysis















Sun Pharmaceutical Industries Ltd.
Biofrontera
Nestle SA
Bausch Health Companies Inc.
Novartis AG
GlaxoSmithKline plc.
Almirall, LLC
LEO Pharma Inc.
Cipher Pharmaceuticals Inc
Pierre Fabre Pharmaceuticals, Inc.
BioLineRX
Alma Lasers
Valeant Pharmaceuticals
3M
Stanford Chemicals.
Inquire further details about this report at: [email protected]
About FutureWise Research:
We specialise in high-growth niche markets, assuring flexibility, agility and
customised solutions for our clients. Through in-depth market insights and
consultancy, we present our clients with the tools they need to be at the forefront of
their industry – a position secured for far more than the near future.
Contact Us:
Company Name: FutureWise Research
Contact Person: Vinay Thaploo
Email: [email protected]
Phone: +44 141 628 9353 / +1 970 279 4295
City: Leeds
Country: United Kingdom
Website: www.futurewiseresearch.com
1/--pages
Report inappropriate content